Kurs & Likviditet
Kalender
2024-11-07 | Kvartalsrapport 2024-Q3 |
2024-08-15 | Kvartalsrapport 2024-Q2 |
2024-05-16 | Kvartalsrapport 2024-Q1 |
2024-03-21 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2024-03-20 | Årsstämma 2024 |
2024-02-27 | Bokslutskommuniké 2023 |
2023-11-09 | Kvartalsrapport 2023-Q3 |
2023-08-17 | Kvartalsrapport 2023-Q2 |
2023-05-11 | Kvartalsrapport 2023-Q1 |
2023-03-30 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2023-03-29 | Årsstämma 2023 |
2023-03-02 | Bokslutskommuniké 2022 |
2022-11-10 | Kvartalsrapport 2022-Q3 |
2022-08-11 | Kvartalsrapport 2022-Q2 |
2022-05-12 | Kvartalsrapport 2022-Q1 |
2022-05-09 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2022-04-06 | Årsstämma 2022 |
2022-03-10 | Bokslutskommuniké 2021 |
2021-11-11 | Kvartalsrapport 2021-Q3 |
2021-08-12 | Kvartalsrapport 2021-Q2 |
2021-05-12 | Kvartalsrapport 2021-Q1 |
2021-04-16 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2021-04-15 | Årsstämma 2021 |
2021-03-11 | Bokslutskommuniké 2020 |
2020-11-12 | Kvartalsrapport 2020-Q3 |
2020-08-13 | Kvartalsrapport 2020-Q2 |
2020-05-14 | Kvartalsrapport 2020-Q1 |
2020-04-03 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2020-04-02 | Årsstämma 2020 |
2020-03-12 | Bokslutskommuniké 2019 |
2019-11-14 | Kvartalsrapport 2019-Q3 |
2019-08-15 | Kvartalsrapport 2019-Q2 |
2019-05-16 | Kvartalsrapport 2019-Q1 |
2019-04-05 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2019-04-04 | Årsstämma 2019 |
2019-03-07 | Bokslutskommuniké 2018 |
2018-11-15 | Kvartalsrapport 2018-Q3 |
2018-08-16 | Kvartalsrapport 2018-Q2 |
2018-05-16 | Kvartalsrapport 2018-Q1 |
2018-04-20 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2018-04-19 | Årsstämma 2018 |
2018-03-07 | Bokslutskommuniké 2017 |
2017-11-08 | Kvartalsrapport 2017-Q3 |
2017-08-24 | Kvartalsrapport 2017-Q2 |
2017-05-17 | Kvartalsrapport 2017-Q1 |
2017-04-06 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2017-04-05 | Årsstämma 2017 |
2017-03-15 | Bokslutskommuniké 2016 |
2016-11-09 | Kvartalsrapport 2016-Q3 |
2016-08-25 | Kvartalsrapport 2016-Q2 |
2016-05-18 | Kvartalsrapport 2016-Q1 |
2016-04-20 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2016-04-19 | Årsstämma 2016 |
2016-03-16 | Bokslutskommuniké 2015 |
2015-11-05 | Kvartalsrapport 2015-Q3 |
2015-08-28 | Kvartalsrapport 2015-Q2 |
2015-05-22 | Kvartalsrapport 2015-Q1 |
2015-04-22 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2015-04-21 | Årsstämma 2015 |
2015-03-12 | Bokslutskommuniké 2014 |
2014-11-07 | Kvartalsrapport 2014-Q3 |
2014-08-21 | Kvartalsrapport 2014-Q2 |
2014-05-06 | Kapitalmarknadsdag 2014 |
2014-04-29 | Kvartalsrapport 2014-Q1 |
2014-04-29 | Årsstämma 2014 |
2014-03-21 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2014-03-20 | Bokslutskommuniké 2013 |
2013-11-15 | Kvartalsrapport 2013-Q3 |
2013-08-29 | Kvartalsrapport 2013-Q2 |
2013-05-15 | Kvartalsrapport 2013-Q1 |
2013-04-30 | Årsstämma 2013 |
2013-04-30 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2013-03-14 | Bokslutskommuniké 2012 |
2012-11-29 | Kapitalmarknadsdag 2012 |
2012-04-26 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2012-04-25 | Årsstämma 2012 |
2011-11-17 | Kvartalsrapport 2011-Q3 |
2011-10-25 | Kapitalmarknadsdag 2011 |
2011-08-18 | Kvartalsrapport 2011-Q2 |
2011-05-12 | Kvartalsrapport 2011-Q1 |
2011-04-29 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2011-04-28 | Årsstämma 2011 |
Beskrivning
Land | Danmark |
---|---|
Lista | Large Cap Copenhagen |
Sektor | Hälsovård |
Industri | Bioteknik |
Press Release – No. 1 / 2024
Zealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on January 4th
Copenhagen, Denmark, January 2, 2024 – Zealand Pharma A/S (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that President and Chief Executive Officer, Adam Steensberg, will participate in a fireside chat at the Goldman Sachs Healthcare C-Suite Unscripted Conference at 10:10 a.m. ET (4:10 p.m. CET) on Thursday, January 4, 2024.
A live audio webcast of the fireside chat will be available at https://event.webcasts.com/starthere.jsp?ei=1650686&tp_key=cc3f20aa04&tp_special=8 and accessible through the company’s website at www.zealandpharma.com/events-cal where a recording of the webcast will also be archived after the event.
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products.
Zealand was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. For more information about Zealand’s business and activities, please visit www.zealandpharma.com.
Contacts:
Adam Lange (Investors) |
Investor Relations Officer |
Zealand Pharma |
alange@zealandpharma.com |
Anna Krassowska, PhD (Investors and Media) |
Vice President, Investor Relations & Corporate Communications |
Zealand Pharma |
akrassowska@zealandpharma.com |